Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

While Cementing Partnership With U.S. Biotech Firm, Cash-rich Simcere Launches Twin Acquisitions Targeting Biosimilar, Vaccine Outfits In China

This article was originally published in PharmAsia News

Executive Summary

BEIJING - Fresh after cementing a new partnership with a San Francisco-based biologics firm, Simcere Pharmaceutical Group has launched twin acquisitions aimed at simultaneously expanding into the biosimilar and vaccine sectors, according to Simcere's leadership

You may also be interested in...



China's Leading Drug Outfits Gear Up To Push Development Of Biologics, Biosimilars

BEIJING - Some of China's leading innovators in drug development are laying the groundwork to become major producers of biopharmaceuticals, including reverse-engineered biosimilars, and sales of biologics have expanded speedily over the last decade

China's Leading Drug Outfits Gear Up To Push Development Of Biologics, Biosimilars

BEIJING - Some of China's leading innovators in drug development are laying the groundwork to become major producers of biopharmaceuticals, including reverse-engineered biosimilars, and sales of biologics have expanded speedily over the last decade

Simcere Subsidiary, Accused Of Illicitly Producing Substandard Rabies Vaccine, Faces Fine Of RMB 25 Million In China

HONG KONG - Simcere Pharmaceutical Group, maker of innovative drugs and branded generics, has announced disappointing first quarter results, hindered by ongoing difficulties at vaccine maker Jiangsu Yanshen Biological Technology and a sales decline for some traditional best sellers

Related Content

UsernamePublicRestriction

Register

SC071747

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel